18F-Fluoride: Benign Bone Disease

Author(s):  
Kalevi Kairemo ◽  
Homer A. Macapinlac
Keyword(s):  
2013 ◽  
Vol 93 (5) ◽  
pp. 436-447 ◽  
Author(s):  
Michelle L. Frost ◽  
Juliet E. Compston ◽  
David Goldsmith ◽  
Amelia E. Moore ◽  
Glen M. Blake ◽  
...  

2015 ◽  
Vol 56 (10) ◽  
pp. 1476-1477 ◽  
Author(s):  
A. Iagaru
Keyword(s):  

1998 ◽  
Vol 37 (02) ◽  
pp. 76-79 ◽  
Author(s):  
T. D. Kirchhoff ◽  
W. Burchert ◽  
J. v. d. Hoff ◽  
H. Zeidler ◽  
H. Hundeshagen ◽  
...  

SummaryA 61-year-old female patient presenting with mixed connective tissue disease (Sharp syndrome), underwent a long-term high dose glucocorticoid treatment because of multiple organ manifestations. Under steroid therapy she developed severe osteoporosis resulting in multiple fractures. A dynamic [18F]fluoride PET study in this patient revealed reduced fluoride influx in non-fractured vertebrae. This finding corresponds to pathogenetic concepts which propose an inhibition of bone formation as major cause of glucocorticoid-induced osteoporosis. In the light of the presented case it seems to be promising to evaluate the diagnostic benefit of [18F]fluoride PET in osteoporosis.


2005 ◽  
Vol 43 (05) ◽  
Author(s):  
A Folhoffer ◽  
P Lakatos ◽  
A Horváth ◽  
T Csak ◽  
J Osztovits ◽  
...  

2013 ◽  
Author(s):  
Adodra Annika ◽  
Kouklinos Andreas ◽  
Julies Priscilla ◽  
Shaw Mathew ◽  
Jacobs Benjamin

Sign in / Sign up

Export Citation Format

Share Document